In the last three years, despite not proving profitable for Medtronic investors, it has still outperformed competitors in the stock market. Even while recording losses, it has been noted to undoubtedly have durable competitive advantages and has been underpinned by financial services and banks like HSBC Holdings. Their increasing appeal to institutional shareholders, who now own 86%-87% of the company is noteworthy. Medtronic is also significantly leveraging Artificial Intelligence in its operations, making it a favourite with investment funds like BlackRock.
The company has also been subject to several price target bumps after successive earnings reports. Despite occasional hiccups, Medtronic has continued to strengthen its position in high-growth markets. The announcement of quarterly dividends, closing of public offerings and FDA approvals have also positively impacted the company's standing. Its financials have sparked some concern as some consider the stock overpriced, and others claim it's subject to a downtrend. However, it still managed to hit a 52-week high at $90.14 quite recently.
Medtronic Plc MDT News Analytics from Tue, 07 Nov 2023 08:00:00 GMT to Sun, 22 Sep 2024 13:00:16 GMT - Rating 7 - Innovation 4 - Information 6 - Rumor 3
